MedTrace Logo

Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled Trial

NCT02434549 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-10-09

No results posted yet for this study

Summary

The purpose of this double-blinded, placebo-controlled study is to test if treatment with Botulinum toxin-A is effective in reducing chronic muscle-related pain in adults with spastic cerebral palsy.

Conditions

  • Pain
  • Cerebral Palsy, Spastic

Interventions

DRUG

Dysport®

Intramuscular injections in spastic muscle with regional muscle-related pain

DRUG

Normal saline

Intramuscular injections in spastic muscle with regional muscle-related pain

Sponsors & Collaborators

  • Danderyd Hospital

    collaborator OTHER

  • Karolinska University Hospital

    collaborator OTHER

  • Kristina Tedroff

    lead OTHER

Principal Investigators

  • Kristina Tedroff, MD, PhD · Associate Professor, Department of Women's and Children's Health, Karolinska Institutet. Senior Consultant Physician, Astrid Lindgren's Children's Hospital, Stockholm, Sweden.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2018-01-26
Completion
2018-10-05

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02434549 on ClinicalTrials.gov